---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-071923"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:17:57.682975+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Globus Medical completes acquisition of Nevro Corp. for $5.85/share cash

## Summary
- Completed acquisition of Nevro on April 3, 2025; each Nevro share received $5.85 in cash.
- Nevro stock options and RSUs canceled; RSUs converted to cash equal to Merger Consideration.
- Acquisition expands Globus's addressable market opportunity to $2 billion in neuromodulation.
- Nevro common stock ceased trading on NYSE as of April 3, 2025.
- Globus plans to discuss merger benefits during Q1 2025 earnings call in May.

## SEC filing metadata
- accession: 0001193125-25-071923
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/0001193125-25-071923-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/d931031d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-071923
- JSON: https://secwatch.observer/filing/0001193125-25-071923.json
- Plain text: https://secwatch.observer/filing/0001193125-25-071923.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.